                                                                                                                                                                                                      0             1
                                                                                                                                                             The application was received by the EMA on  4 April 2019
                                                                                                                                                                               The procedure started on 29 April 2019
                                                                                                         The Rapporteur's first CHMP and PRAC Assessment Report was circulated \nto all CHMP members on   3 June 2019
                                                                                                             The PRAC agreed on the PRAC Assessment Overview and Advice to CHMP \nduring the meeting on  14 June 2019
The CHMP, in the light of the overall data submitted and the scientific \ndiscussion within the Committee, issued a positive opinion for granting a \nmarketing authorisation to Azacitidine Celgene on  27 June 2019